Drug company gives ofatumumab update
Drug company gives ofatumumab update
Biotech firm Genmab has announced an update on development plans for ofatumumab in autoimmune indications focusing on relapsing multiple sclerosis following the transfer of the rights to ofatumumab from GlaxoSmithKline (GSK) to Novartis at the end of 2015...Read more - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1379 Views
-
Last post by frodo
-
- 0 Replies
- 1021 Views
-
Last post by frodo
-
- 0 Replies
- 2536 Views
-
Last post by NHE
-
- 0 Replies
- 1306 Views
-
Last post by frodo
-
- 0 Replies
- 1293 Views
-
Last post by frodo
-
- 0 Replies
- 1271 Views
-
Last post by frodo
-
- 0 Replies
- 1643 Views
-
Last post by NHE
-
- 0 Replies
- 480 Views
-
Last post by NHE
-
- 1 Replies
- 3118 Views
-
Last post by Tif